Clinical Trial Update: Immunology of Ebola Vaccine [Phase 2]

View source ↗

Summary

An update on a Phase 2 immunology study of an Ebola vaccine sponsored by Emory University; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: Emory University | Conditions: Ebola Virus Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING